Mumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first ...

Meanwhile, the company's board declared an interim dividend of Rs 4 per share for FY26, The company has fixed 8 August 2025, ...

Alembic Pharmaceuticals reports 14.6% profit rise in Q1, driven by strong U.S. and India sales, launching 4 new products.

India's Alembic Pharmaceuticals reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India. The firm's consolidated profit rose to 1.54 ...

Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of ₹824.20 Crore in the quarter under review, down by 10.20% on ...

Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter ...

Mumbai :Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Stocks including Paytm, Aditya Infotech, Bosch, Laxmi India Finance, Aurobindo Pharma, DLF, Bharti Airtel, Siemens Energy and ...

GIFT Nifty Futures were trading down marginally by 17 points at 24,767, indicating a flat or slight negative opening.

Domestic equity benchmarks halted a two-day losing streak amid buying in IT, energy and auto shares on Monday, though selling ...

Track top stocks like Tata Motors, IndusInd Bank, Kaynes Tech, and more as key updates and earnings could drive action ...